3Boozer CN, Daly PA, Solomon JL, et al. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat Metab Disord, 2002, 26 (5): 593-604.
4Morgenstem LB, Viscoli CM, Kernan WN, et al. Use of ephedra containing products and risk for hemorrhagic stroke. Neurology, 2003, 60 (1):132-135.
5Kalman D, Ineledon T, Gaunaurd I, et al. An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra caffeine weight loss product in healthy overweight adults. Int J Obes Relat Metab Disord,2002, 26 (10): 1363-1366.
6Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med, 2000, 343 (25): 1833-1838.
7Boerth JM, Caley CF. Possible ease of mania associated with ma-huang.Pharmacotherapy, 2003, 23 (3): 380-383.
8Rezkalla SH, Mesa J, Sharma P, et al. Myocardial infarction temporally related to ephedra--a possible role for the coronary microcirculation.WMJ, 2002, 101 (7): 64-46.
9Lee MK, Cheng BW, Che CT, et al. Cytotoxicity assessment of ma-huang (ephedra) under different conditions of preparation. Toxicol Sci,2000, 56 (2): 424-430.
10Shekelle PG, Hardy ML, Morton SC, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.JAMA, 2003, 289 (12): 1537-1545.
